World
U.S. Missile Stockpile Dwindles; FDA Considers mRNA Flu Shot
The U.S. Army's missile stockpile is facing a significant shortage and could take years to replenish, while the FDA considers approving an mRNA flu vaccine.
Coverage timeline — 1 article
NPR
The U.S. Army's missile stockpile is dwindling and could take years to replenish. And, the Food and Drug Administration is deciding whether to approve a flu vaccine with mRNA technology.
2026-08-05 11:54 UTC